Exact Mass: 538.2904
Exact Mass Matches: 538.2904
Found 500 metabolites which its exact mass value is equals to given mass value 538.2904
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
BATRACHOTOXIN
Ulimorelin
Prolyl-phenylalanyl-arginine-4-nitroanilide
Colossolactone VIII
A tetracyclic triterpenoid that is A,B-dihomo-19-nor-4-oxalanosta-1,8,19,24-tetraen-26,22-olide substituted by an acetoxy group at position 15, a hydroxy group at position 23 and an oxo group at position 3 (the 22S, 23R stereoisomer). It is isolated from the fruiting bodies of the Vietnamese mushroom Ganoderma colossum and displays inhibitory activity towards the enzyme HIV protease.
6alpha-Hydroxy-23xi-methoxy-3-oxo-7alpha-senecioyloxy-24,25,26,27-tetranorapotirucalla(apoeupha)-1,14,20(22)-trieno-21,23-lactone|7-O-Deacetyl-23-O-methyl-7alpha-O-senecioylnimocinolide
11-O-Cinnamoyl,12-Ac-(3beta,5alpha,11alpha,12beta,14beta)-3,11,12,14-Tetrahydroxypregnan-20-one
(22S,23R)-A,B-dihomo-19-nor-15-beta-acetoxy-23-hydroxy-4-oxa-3-oxolanosta-1,8,19,24-tetraen-26,22-olide|colossolactone VIII
5-Cinnamoyl-9-O-acetylphototaxicin I|5-E-cinnamoyl-10-acetylphototaxicin I
bipindogenin-3beta-O-(beta-D-riboside)|bipindogenin-3beta-O-
1beta,2alpha,9alpha-trihydroxy-10beta-acetoxy-5alpha-cinnamoyloxy-3,11-cyclotaxa-4(20)-en-13-one|5-Cinnamoyl-10-acetylphototaxicin-I|5alpha-cinnamoyl-9alpha-acetylphototaxicin I
(20SR,22RS)-5alpha,6beta,14alpha,15alpha,17beta,20,27-heptahydroxy-1-oxowith-24-enolide|coagulin S
(20R,22R)-6-oxo-2beta,3beta,5,14alpha,20,25-hexahydroxy-5beta-cholest-7-en-22-yl acetate|polypodin B 22-acetate|polypodine B 22-acetate|polypodine B-22-O-acetate
3R,5R,6S,7E,9R-megastigman-7-en-3,5,6,9-tetrol-9-O-beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranoside
(12E,2S,3S,4R,5R,6S,9S,11R,15R)-3-benzoyloxy-5,15-diacetoxy-6,17-epoxylathyra-12-en-14-one
(3S,5R,6R,9S)-megastigman-3,6,9-triol 9-O-alpha-L-rhamnopyranosyl-(1?2)-beta-D-glucopyranoside|pteleifoside A
3-deisobutyryl-3-O-methacryloylgranatumin H|granatumin I|methyl rel-(4R,4aR,6aS,7R,8S,10R,11S,12bS)-4-(furan-3-yl)-1,4,4a,5,6,6a,7,8,9,10,11,12b-dodecahydro-4a,7,9,9-tetramethyl-10-[(2-methyl-1-oxoprop-2-en-1-yl)oxy]-2,13-dioxo-7,11-methano-2H-cycloocta[3,4]benzo[1,2-c]pyran-8-acetate
10beta-hydroxy-19-norperiplogenin-3beta-O-alpha-L-rhamnopyranose|toxicarioside M
1alpha,6alpha,7beta-triacetoxy-5alpha-hydroxy-16,16-dimethoxy-12-oxocassa-13(14)-diene|caesalpin C
3-hydroxymethyl-5-(3-hydroxypropyl)-7-methoxy-2-{3-methoxy-4-[1-(3,4-dimethoxybenzyl)-2-hydroxyethyl]phenyl}-2,3-dihydrobenzofuran
Gln Tyr Thr Lys
Asn His Ile Arg
His Val Gln Arg
Tyr Gln Thr Lys
Gln Val His Arg
C28H42O10_4H-Cyclopenta[a]cyclopropa[f]cycloundecen-4-one, 4a-(acetyloxy)-9-[(hexopyranosyloxy)methyl]-1,1a,4a,5,6,7,7a,10,11,11a-decahydro-7-hydroxy-1,1,3,6-tetramethyl-, (8E)
Ala His Arg Arg
Ala Arg His Arg
Ala Arg Arg His
Phe Phe Ile Ile
Phe Phe Ile Leu
Phe Phe Leu Ile
Phe Phe Leu Leu
Phe His His Val
Phe His Val His
Phe Ile Phe Ile
Phe Ile Phe Leu
Phe Ile Ile Phe
Phe Ile Leu Phe
Phe Ile Pro Tyr
Phe Ile Tyr Pro
Phe Lys Met Asn
Phe Lys Asn Met
Phe Leu Phe Ile
Phe Leu Phe Leu
Phe Leu Ile Phe
Phe Leu Leu Phe
Phe Leu Pro Tyr
Phe Leu Tyr Pro
Phe Met Lys Asn
Phe Met Asn Lys
Phe Asn Lys Met
Phe Asn Met Lys
Phe Pro Ile Tyr
Phe Pro Leu Tyr
Phe Pro Tyr Ile
Phe Pro Tyr Leu
Phe Val His His
Phe Tyr Ile Pro
Phe Tyr Leu Pro
Phe Tyr Pro Ile
Phe Tyr Pro Leu
His Ala Arg Arg
His Phe His Val
His Phe Val His
His His Phe Val
His His Val Phe
His Ile Asn Arg
His Ile Arg Asn
His Leu Asn Arg
His Leu Arg Asn
His Asn Ile Arg
His Asn Leu Arg
His Asn Arg Ile
His Asn Arg Leu
His Gln Arg Val
His Gln Val Arg
His Arg Ala Arg
His Arg Ile Asn
His Arg Leu Asn
His Arg Asn Ile
His Arg Asn Leu
His Arg Gln Val
His Arg Arg Ala
His Arg Val Gln
His Val Phe His
His Val His Phe
His Val Arg Gln
Ile Phe Phe Ile
Ile Phe Phe Leu
Ile Phe Ile Phe
Ile Phe Leu Phe
Ile Phe Pro Tyr
Ile Phe Tyr Pro
Ile His Asn Arg
Ile His Arg Asn
Ile Ile Phe Phe
Ile Ile Met Tyr
Ile Ile Tyr Met
Ile Leu Phe Phe
Ile Leu Met Tyr
Ile Leu Tyr Met
Ile Met Ile Tyr
Ile Met Leu Tyr
Ile Met Tyr Ile
Ile Met Tyr Leu
Ile Asn His Arg
Ile Asn Arg His
Ile Pro Phe Tyr
Ile Pro Tyr Phe
Ile Arg His Asn
Ile Arg Asn His
Ile Tyr Phe Pro
Ile Tyr Ile Met
Ile Tyr Leu Met
Ile Tyr Met Ile
Ile Tyr Met Leu
Ile Tyr Pro Phe
Lys Phe Met Asn
Lys Phe Asn Met
Lys Lys Thr Tyr
Lys Lys Tyr Thr
Lys Met Phe Asn
Lys Met Asn Phe
Lys Asn Phe Met
Lys Asn Met Phe
Lys Gln Thr Tyr
Lys Gln Tyr Thr
Lys Thr Lys Tyr
Lys Thr Gln Tyr
Lys Thr Tyr Lys
Lys Thr Tyr Gln
Lys Tyr Lys Thr
Lys Tyr Gln Thr
Lys Tyr Thr Lys
Lys Tyr Thr Gln
Leu Phe Phe Ile
Leu Phe Phe Leu
Leu Phe Ile Phe
Leu Phe Leu Phe
Leu Phe Pro Tyr
Leu Phe Tyr Pro
Leu His Asn Arg
Leu His Arg Asn
Leu Ile Phe Phe
Leu Ile Met Tyr
Leu Ile Tyr Met
Leu Leu Phe Phe
Leu Leu Met Tyr
Leu Leu Tyr Met
Leu Met Ile Tyr
Leu Met Leu Tyr
Leu Met Tyr Ile
Leu Met Tyr Leu
Leu Asn His Arg
Leu Asn Arg His
Leu Pro Phe Tyr
Leu Pro Tyr Phe
Leu Arg His Asn
Leu Arg Asn His
Leu Tyr Phe Pro
Leu Tyr Ile Met
Leu Tyr Leu Met
Leu Tyr Met Ile
Leu Tyr Met Leu
Leu Tyr Pro Phe
Met Phe Lys Asn
Met Phe Asn Lys
Met Ile Ile Tyr
Met Ile Leu Tyr
Met Ile Tyr Ile
Met Ile Tyr Leu
Met Lys Phe Asn
Met Lys Asn Phe
Met Leu Ile Tyr
Met Leu Leu Tyr
Met Leu Tyr Ile
Met Leu Tyr Leu
Met Asn Phe Lys
Met Asn Lys Phe
Met Tyr Ile Ile
Met Tyr Ile Leu
Met Tyr Leu Ile
Met Tyr Leu Leu
Asn Phe Lys Met
Asn Phe Met Lys
Asn His Leu Arg
Asn His Arg Ile
Asn His Arg Leu
Asn Ile His Arg
Asn Ile Arg His
Asn Lys Phe Met
Asn Lys Met Phe
Asn Leu His Arg
Asn Leu Arg His
Asn Met Phe Lys
Asn Met Lys Phe
Asn Arg His Ile
Asn Arg His Leu
Asn Arg Ile His
Asn Arg Leu His
Pro Phe Ile Tyr
Pro Phe Leu Tyr
Pro Phe Tyr Ile
Pro Phe Tyr Leu
Pro Ile Phe Tyr
Pro Ile Tyr Phe
Pro Leu Phe Tyr
Pro Leu Tyr Phe
Pro Tyr Phe Ile
Pro Tyr Phe Leu
Pro Tyr Ile Phe
Pro Tyr Leu Phe
Gln His Arg Val
Gln His Val Arg
Gln Lys Thr Tyr
Gln Lys Tyr Thr
Gln Arg His Val
Gln Arg Val His
Gln Thr Lys Tyr
Gln Thr Tyr Lys
Gln Val Arg His
Gln Tyr Lys Thr
Arg Ala His Arg
Arg Ala Arg His
Arg His Ala Arg
Arg His Ile Asn
Arg His Leu Asn
Arg His Asn Ile
Arg His Asn Leu
Arg His Gln Val
Arg His Arg Ala
Arg His Val Gln
Arg Ile His Asn
Arg Ile Asn His
Arg Leu His Asn
Arg Leu Asn His
Arg Asn His Ile
Arg Asn His Leu
Arg Asn Ile His
Arg Asn Leu His
Arg Gln His Val
Arg Gln Val His
Arg Arg Ala His
Arg Arg His Ala
Arg Val His Gln
Arg Val Gln His
Thr Lys Lys Tyr
Thr Lys Gln Tyr
Thr Lys Tyr Lys
Thr Lys Tyr Gln
Thr Gln Lys Tyr
Thr Gln Tyr Lys
Thr Tyr Lys Lys
Thr Tyr Lys Gln
Thr Tyr Gln Lys
Val Phe His His
Val His Phe His
Val His His Phe
Val His Gln Arg
Val His Arg Gln
Val Gln His Arg
Val Gln Arg His
Val Arg His Gln
Val Arg Gln His
Tyr Phe Ile Pro
Tyr Phe Leu Pro
Tyr Phe Pro Ile
Tyr Phe Pro Leu
Tyr Ile Phe Pro
Tyr Ile Ile Met
Tyr Ile Leu Met
Tyr Ile Met Ile
Tyr Ile Met Leu
Tyr Ile Pro Phe
Tyr Lys Lys Thr
Tyr Lys Gln Thr
Tyr Lys Thr Lys
Tyr Lys Thr Gln
Tyr Leu Phe Pro
Tyr Leu Ile Met
Tyr Leu Leu Met
Tyr Leu Met Ile
Tyr Leu Met Leu
Tyr Leu Pro Phe
Tyr Met Ile Ile
Tyr Met Ile Leu
Tyr Met Leu Ile
Tyr Met Leu Leu
Tyr Pro Phe Ile
Tyr Pro Phe Leu
Tyr Pro Ile Phe
Tyr Pro Leu Phe
Tyr Gln Lys Thr
Tyr Thr Lys Lys
Tyr Thr Lys Gln
Tyr Thr Gln Lys
TMC-1C
A polyene antibiotic that is TMC-1A in which the 2,4-dimethyloct-2-enoyl group has been replaced by an (E,E)-4,6-dimethyldeca-2,4-dienoyl group. TMC-1C is an antitumour antibiotic isolated from Streptomyces sp. A-230.
1,1-[(5E)-5-Methyl-7-oxo-5-undecene-1,11-diyl] Bis
(5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]oxalate
1,3,3-trimethyl-2-[2-[3-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]-2H-pyran-5-ylidene]ethylidene]indole,tetrafluoroborate
Pentolinium Tartrate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Ulimorelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue C78281 - Agent Affecting Musculoskeletal System > C1935 - Anticachexia Agent > C84868 - Ghrelin Peptide Analogue
Prolyl-phenylalanyl-arginine-4-nitroanilide
[(3E,10E)-13-hydroxy-3,6,6,14-tetramethyl-2-oxo-10-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1-tricyclo[10.3.0.05,7]pentadeca-3,10-dienyl] acetate
14-hydro-15-hydroxyajugachin A
A diterpenoid isolated from Ajuga bracteosa and has been shown to exhibit antifeedant activity.
1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-[2-(3-methylphenyl)ethyl]-3-[3-(4-morpholinyl)propyl]thiourea
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[(2S,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[(2S,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2S,3R)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
8-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxynonanoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-heptadec-9-enoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-tridec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate
(2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide
WAY-100635 (maleate)
WAY-100635 maleate is a potent and selective 5-hydroxytryptamine 1A (5-HT1A) receptor antagonist with an IC50 value of 0.91 nM and Ki value of 0.39 nM. WAY-100635 maleate has pIC50 values for 5-HT1A and α1-adrenergic receptors of 8.9 and 6.6, respectively. WAY-100635 maleate is also a potent dopamine D4 receptor agonist[1][2][3].
6,9-dihydroxy-7-methyl-14-(3-methylbut-2-en-1-yl)-4-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10(15),11,13-tetraen-3-one
(9r,13r,14r,16r,17r,19s)-19-hydroxy-8,8,13,17-tetramethyl-16-[(1s)-1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-14-yl acetate
(1r,2s,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-ethoxy-hexahydrofuro[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(2r)-n-[(2s)-1-[(2s,3ar,5s,6s,7as)-2-{[2-(1-carbamimidoyl-2,5-dihydropyrrol-3-yl)ethyl]carbamoyl}-5,6-dihydroxy-octahydroindol-1-yl]-3-methyl-1-oxobutan-2-yl]-3-hydroxy-2-methoxypropanimidic acid
8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-{hexahydrofuro[2,3-b]furan-2-yl}-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylpropanoate
(2r,3r)-2-[(1s,3as,5as,7r,8s,9ar,9br,11ar)-3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl acetate
(9s,10r,13s,16r,17r,18s)-10-hydroxy-8,8,13,17-tetramethyl-16-[(1s)-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-18-yl acetate
(2s,3r,4s,5r,6r)-2-{[(1s,3r,4r)-3,4-dihydroxy-4-[(1e,3r)-3-hydroxybut-1-en-1-yl]-3,5,5-trimethylcyclohexyl]oxy}-6-({[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(1r,2s,3s,4ar,5s,6r,8s,8ar)-5-[(2r,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl 2-methylpropanoate
3-[(1r,2r,3s,5r,6r,10s,11s,13r)-3-acetyl-2,6,10-trimethyl-5-[(1z)-1-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]prop-1-en-2-yl]-7-oxo-11-(prop-1-en-2-yl)-14-oxatetracyclo[7.5.0.0¹,¹³.0²,⁶]tetradec-8-en-10-yl]propanoic acid
(1s,4r,12s,14s,17z,29s)-12,29-dihydroxy-19,19-dimethyl-5-(2-methylbut-3-en-2-yl)-3,5,16,21-tetraazaheptacyclo[14.13.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0²⁰,²⁸.0²²,²⁷]nonacosa-6,8,10,17,20(28),22,24,26-octaene-2,15-dione
n-[5-({7-hydroxy-3-[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-2-yl}methyl)-2,6a-dimethyl-6-oxo-1ah,2h,6bh-oxireno[2,3-a]pyrrolizin-4-yl]-3-methylbut-2-enimidic acid
(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-valeramide
{"Ingredient_id": "HBIN006727","Ingredient_name": "(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-valeramide","Alias": "(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxo-pentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-methanoylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(1S)-1-carbamoyl-3-methylbutyl]-2-[[(2S)-2-dimethylamino-1-oxo-3-phenylpropyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenylpropanoyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide","Ingredient_formula": "C30H42N4O5","Ingredient_Smile": "NA","Ingredient_weight": "538.68","OB_score": "15.65957604","CAS_id": "107494-21-3","SymMap_id": "SMIT03939","TCMID_id": "NA","TCMSP_id": "MOL001538","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}